1. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s Kannaway Announces Expansion of Executive Leadership Team

    GlobeNewswire – 9:00 AM ET 08/27/2015

    Medical Marijuana, Inc.'s Kannaway is proud to announce the addition of Mr. Bradley J. Tayles as Vice President of Operations. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=35610. "We are very fortunate that Brad Tayles joined the Kannaway organization and welcome him to our team," states Jeff Rogers, Chief Executive Officer of Kannaway.

  2. Show article details.

    Medical Marijuana, Inc's Portfolio Investment Company Kannalife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents

    GlobeNewswire – 9:00 AM ET 08/14/2015

    Medical Marijuana, Inc. (MJNA) portfolio investment company Kannalife Sciences, Inc. has announced the publication of its global WIPO/PCT Patent WO2015/106108A2 – 'Novel Functionalized 1,3-Benzene Diols and Their Method of Use for the Treatment of Hepatic Encephalopathy'. Both hepatic encephalopathy and chronic traumatic encephalopathy are oxidative stress related diseases.

  3. Show article details.

    MJNA's Investment Company AXIM Biotech Announces Clinical Trial Launch of MedChew RX for Treatment of Pain and Spasticity in Multiple Sclerosis and Development of Pharmaceutical Cannabis Chewing Gum

    GlobeNewswire – 9:00 AM ET 08/13/2015

    Medical Marijuana, Inc. (MJNA) is an agricultural hemp industry innovator that sources, evaluates, invests in and acquires value-adding companies with a focus on industrial hemp. Pain management medications are coming under increased scrutiny, as is evidenced by FDA warnings on the safety of nonsteroidal anti-inflammatory drugs from July 2015.

  4. Show article details.

    Medical Marijuana, Inc.'s HempMeds Expands Into Asian Market With Its First Distributor Agreeing to an Initial Purchase Order of 2,000,000 USD in Hemp CBD Oil Products

    GlobeNewswire – 9:00 AM ET 08/12/2015

    HempMeds®, an MJNA portfolio company and the Company's master distributor, is pleased to announce to shareholders and the public that it is expanding sales through HempMeds® South Korea, an exclusive distributor, responsible for marketing and sales of the Company's cannabidiol hemp oil products.

  5. Show article details.

    HempMeds, A Medical Marijuana, Inc. - Hemp CBD Oil Subsidiary, Named Title Sponsor at Hope4Harper's "Run4Hope" 5K Fundraiser for CDKL5 Epilepsy Research

    GlobeNewswire – 3:30 PM ET 08/11/2015

    HempMeds® is proud to announce it will be this year's title sponsor of Hope4Harper's 4th Annual "Run4Hope" 1-Mile Kids Fun Run & 5K that takes place Saturday, September 12 at Andy Brown Park East in Coppell, TX. The organization raises funds to research Cyclin Dependent Kinase Like 5, CDKL5, epilepsy and seizure-related disorders.

  6. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s HempMeds Featured on NBC 7 Discussing Cannabis in Pro Sports From Growing Industry Hub: San Diego

    GlobeNewswire – 1:49 PM ET 08/11/2015

    San Diego's economic development is being fueled by one of the oldest plants on the planet: cannabis. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=35086.

  7. Show article details.

    Photo Release -- Medical Marijuana, Inc. and HempMeds Brasil(TM) Celebrate 15 Year-Old Boy's Free Access to RSHO Hemp CBD Oil -- Subsidized by the Brazilian Government

    GlobeNewswire – 9:00 AM ET 08/05/2015

    Medical Marijuana, Inc. (MJNA) is proud to announce, through its partnership with HempMeds Brasil™, that the Brazilian government has subsidized the cost of a 30-day supply of Real Scientific Hemp Oil™ (RSHO, the cannabidiol hemp oil brand) for 15 year-old Gabriel César do Amaral.

  8. Show article details.

    Photo Release -- HempMeds(R) Congratulates Harper Howard as 2015 Miss Texas Princess Cover Girl at The National American Miss Pageant, NAMISS

    GlobeNewswire – 1:00 PM ET 08/04/2015

    Medical Marijuana, Inc. (MJNA) and its portfolio company, HempMeds®, congratulates 5-year-old Harper Howard of Hope4Harper, who was crowned the 2015 National American Miss Texas Princess Cover Girl this weekend at the regional pageant held in North Texas. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=34933.

  9. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s RSHO(TM) Appears in Wall Street Journal Article About New York Medical Marijuana Licenses

    GlobeNewswire – 9:00 AM ET 08/04/2015

    Medical Marijuana, Inc. (MJNA) is pleased that its flagship cannabidiol hemp oil brand, Real Scientific Hemp Oil™ appeared in the Wall Street Journal on July 31st 2015, as part of the paper's coverage of New York State medical marijuana license recipients. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=34911.

  10. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s HempMeds Sponsors San Diego Cannabis Professionals Cup

    GlobeNewswire – 9:00 AM ET 08/03/2015

    San Diego's HempMeds™ is proud to announce its support for the cannabis industry as a presenting sponsor at the 1st annual San Diego Cannabis Professionals Cup. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=34857.

  11. Show article details.

    Medical Marijuana, Inc.'s CanChew -- Patented Cannabis Gum -- Featured in ABC, NBC, CBS, Yahoo! News and More From Chicago Cannabis Convention

    GlobeNewswire – 9:00 AM ET 07/30/2015

    As Illinois implements the state's accessibility to medical cannabis, many patients, healthcare and legal professionals exchanged knowledge and resources at the 2nd annual My Compassion Chicago Cannabis Conference at Navy Pier July 23-25.

  12. Show article details.

    Medical Marijuana, Inc. Successfully Defeats Project CBD's Anti-SLAPP Motion and Motion to Reconsider in $100 Million False Claims Lawsuit

    GlobeNewswire – 9:00 AM ET 07/28/2015

    Medical Marijuana, Inc. (MJNA) announced in October that it filed a $100 million lawsuit against multiple companies that published false allegations about Medical Marijuana, Inc. (MJNA) its portfolio companies and CBD hemp oil brands.

  13. Show article details.

    Medical Marijuana, Inc. Announces Settlement of Major Pending Litigation With CannaVest and Ownership of Key Brands

    GlobeNewswire – 9:30 AM ET 07/22/2015

    Medical Marijuana, Inc. (MJNA), a leading industrial hemp industry innovator, is pleased to announce to shareholders and the general public that it has entered into a final global settlement of all litigation with CannaVest Corp. Under the terms of the settlement, the Company has secured its ownership of all intellectual property and branding related to Real Scientific Hemp Oil™ and Cannabis Beauty ...

  14. Show article details.

    Medical Marijuana, Inc.'s Video Statement on Investment Portfolio's Historic Accomplishments and Supporting the Science Behind Cannabis Legalization

    GlobeNewswire – 10:15 AM ET 07/15/2015

    "Honestly, if you and I would have sat here two or three years ago, people would be saying, 'I would never invest in marijuana stocks,'" states Andrew Hard, CEO of CMW Media and Spokesperson for Medical Marijuana, Inc. (MJNA) during an interview by Cannabis Financial Network.

  15. Show article details.

    Photo Release -- Medical Marijuana, Inc., Partnership HempMeds Brasil: Real Scientific Hemp Oil (RSHO) Import Tax Waived by Brazilian Government

    GlobeNewswire – 9:00 AM ET 07/14/2015

    Medical Marijuana, Inc. (MJNA), an industrial hemp industry innovator and investor, is proud to announce that through its partnership with HempMeds Brasil™, import taxes are now waived on shipments of Real Scientific Hemp Oil™ with ANVISA registration and documentation. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=34446.

  16. Show article details.

    Photo Release -- Medical Marijuana, Inc. Subsidiary Kannaway's Role in Historic Legalization of Puerto Rico Captured in Global Headlines and Web Documentary

    GlobeNewswire – 9:00 AM ET 07/09/2015

    A new article in Caribbean Business and a just-released YouTube web documentary video capture the historic efforts of Medical Marijuana, Inc. (MJNA) subsidiary Kannaway to educate and open up a major market in Puerto Rico by teaching residents about cannabidiol hemp oil products leading up to the island's historic legalization.

  17. Show article details.

    Medical Marijuana, Inc.'s CEO Announces Vision for Hemp Industry Revolution in Video Statement

    GlobeNewswire – 9:00 AM ET 07/02/2015

    In a video statement, Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. (MJNA), makes it clear what the Company's vision and mission is: inspire change. The U.S. legal cannabis industry is valued at $2.7 billion and, with full legalization, the projected value is $36.8 billion.

  18. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s Dixie Botanicals Launches New Peppermint Flavor CBD Hemp Oil Drops

    GlobeNewswire – 1:30 PM ET 07/01/2015

    Medical Marijuana, Inc. (MJNA), an industrial hemp industry innovator, is proud to announce that its portfolio company, Dixie Botanicals™, one of the most widely recognized brands in the cannabis industry, has launched Hemp Stalk Oil Dew Drops® in an all-new flavor: peppermint.

  19. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s HempMeds' RSHO Pure Quality Verified by Top Cannabis Industry Laboratory: ProVerde

    GlobeNewswire – 9:15 AM ET 07/01/2015

    Video Statement by Dorian Des Lauriers, CEO of ProVerde Laboratories, Verifies Pure Quality of Medical Marijuana, Inc.'s CBD Hemp Oil Brands Including Real Scientific Hemp Oil™, Others from HempMeds® SAN DIEGO, July 1, 2015 -- Medical Marijuana, Inc. (MJNA), an industrial hemp industry innovator and investor, released a video statement from one of the cannabis industry's top product quality testing...

  20. Show article details.

    Medical Marijuana, Inc. Announces Investment in AXIM Biotechnologies

    GlobeNewswire – 9:30 AM ET 06/30/2015

    Medical Marijuana, Inc. (MJNA) would like to inform the public and shareholders that it holds 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies (AXIM), a cutting-edge biotechnology innovator.

Page:

Today's and Upcoming Events

No events in the next 90 days

Past Events (last 90 days)

No events in the past 90 days

Data provided by Wall Street Horizon, Inc. © 2015

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.